The Association for Research in Vision and Ophthalmology (ARVO) today recognized the 2021 class of its popular Women’s Leadership Development Program (WLDP).
Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research, funded by Research to Prevent Blindness, an anonymous donor, and the Association of University Professors of Ophthalmology.
The vision community and its coalition partners announce awareness and educational activities in July 2021 around the annual recognition of Dry Eye Awareness Month.
New research in flies indicates that prediction may be a universal principle among animal nervous systems to enable rapid behavioral changes.
The Association for Research in Vision and Ophthalmology (ARVO) has announced the election of new Editors-in-Chief (EICs) for its three open-access journals — Investigative Ophthalmology & Visual Science (IOVS), Journal of Vision (JOV) and Translational Vision Science & Technology (TVST).
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Ludwig von Sallmann Clinician-Scientist Award. The award, which recognizes Ludwig von Sallmann, MD, honors awardees with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Sai Chavala, MD, of Texas Christian University (TCU) and The University of Northern Texas Health Science Center (UNTHSC) School of Medicine in Fort Worth, Texas.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Oberdorfer Award in Low Vision Research. The award, which honors Michael D. Oberdorfer, PhD, recognizes a recipient with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Caroline Klaver, MD, PhD of Erasmus Medical Center, Radboud University Medical Center, and the Institute of Molecular and Clinical Ophthalmology Basel (IOB).
As regenerative therapies for blinding diseases move closer to clinical trials, the National Eye Institute’s functional imaging consortium, a part of the NEI Audacious Goals Initiative (AGI), is pioneering noninvasive technologies to monitor the function of the retina’s light-sensing neurons and their connections to the brain.
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients’ vision, according to initial data from a clinical trial.
A Penn Medicine patient with a genetic form of childhood blindness gained vision, which lasted more than a year, after receiving a single injection of an experimental RNA therapy into the eye.
The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit of glaucoma research. The TGF (sponsored by Patricia Hill) / RPB Fellowships in Glaucoma provide one-year, $10,000 fellowships focused on substantive glaucoma research.
A meta-analysis finds that vision impairment and blindness are tied to an increased risk of mortality, prompting the need to address global eye health disparities.
Using neutron experiments and computer simulations, researchers from Oak Ridge National Laboratory delved into how some of the proposed COVID-19 drug candidates behave at the molecular scale when exposed to water.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Pfizer Ophthalmics Carl Camras Translational Research Award. The award, funded by Pfizer Ophthalmics through the ARVO Foundation, honors Dr. Carl Camras, who is highly respected for his work as a glaucoma specialist and a research scientist, by annually awarding up to three $12,000 awards to young investigators working in areas of translational research. The 2021 awardee is Alex Huang, MD, PhD of the Doheny Eye Institute and University of California in Los Angeles.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Mallinckrodt Uveitis Research Fellowship, generously funded by Mallinckrodt Pharmaceuticals. The award, funded through the ARVO Foundation, supports an early career investigator with a one-year grant of $45,000 to study an aspect of uveitis or other inflammatory conditions of the eye. The 2021 awardee is Shilpa Kodati, MD of the National Eye Institute (NEI) at the National Institutes of Health (NIH).
The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Dr. David L. Epstein Award. Jamie Craig, MBBS, FRANZCO, DPhil and Owen Siggs, MD, DPhil, are the recipients of the $100,000 award which is funded through the ARVO Foundation.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Roche Collaborative Research Fellowships. Wanjiku Mathenge MBChB, MMed, MSc, PhD, Sudhir H Ranganath, PhD, and Pablo Federico Barcelona, PhD, are the recipients of the fellowships that are generously funded by F. Hoffmann-La Roche Ltd., through the ARVO Foundation.
The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipients of the Lewis Rudin Glaucoma Prize. The award, funded by the May and Samuel Rudin Family Foundation with support of his brother Jack Rudin via the ARVO Foundation, provides a $30,000 award in recognition of an outstanding scholarly article on glaucoma published in a peer-reviewed journal during the previous calendar year. The 2020 recipients are Iqbal Ahmad Ph.D. and Pooja Teotia, PhD, of the University of Nebraska in Omaha, Neb.
The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the 2021 Genentech Age-Related Macular Degeneration (AMD) Research Fellowships. The two recipients will each receive $40,000 to support research focused on an aspect of AMD. The 2021 recipients are Yi-Rong Peng, PhD and Kevin J. McHugh, PhD.
The Association for Research in Vision and Ophthalmology (ARVO) today announced Yohei Tomita, MD, PhD, has received the 2021 Bert M. Glaser, MD Award for Innovative Research in Retina, which recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition. Tomita is recognized with this award for his retinal translational research, with a focus on diabetic retinopathy (DR) and age-related macular degeneration (AMD).
New data published in the Journal Science Translational Medicine shows encouraging results in a worldwide clinical trial for patients diagnosed with the neuro-degenerative blinding eye disease; Leber Hereditary Optic Neuropathy (LHON.)
Three University of Michigan researchers say eye care accessibility around the globe isn’t keeping up with an aging population, posing challenges for eye care professionals over the next 30 years.
Ancient deep sea creatures called radiodonts had incredible vision that likely drove an evolutionary arms race according to new research published today.
Multiple honors recognize leadership and exemplary scientific and educational contributions
The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the inaugural 2020 Advocacy Awards. The recipient of the Achievements in Eye and Vision Advocacy Award is João M. Furtado, MD, PhD of the Ribeirão Preto Medical School, University of São Paulo. The recipient of the Emerging Advocate Award is Jarrod C. Harman of Louisiana State University Health Sciences Center (LSUHSC).
When startled, do all fish respond the same way? A few fish, like Mexican cavefish, have evolved in unique environments without any predators. To see how this lack of predation impacts escape responses that are highly stereotyped across fish species, scientists explored this tiny fish to determine if there are evolved differences in them. Findings reveal that the dramatic ecological differences between cave and river environments contribute to differences in escape behavior in blind cavefish and river-dwelling surface cavefish.
A breakthrough study, led by researchers from the University of California, Irvine, results in the restoration of retinal and visual functions of mice models suffering from inherited retinal disease.
The coronavirus pandemic has shifted many of our interactions online, with Zoom video calls
replacing in-person classes, work meetings, conferences and other events. Will all that screen time damage our vision? Maybe not. It turns out that our visual perception is highly adaptable, according to research from Psychology Professor and Cognitive and Brain Sciences Coordinator Peter Gerhardstein’s
lab at Binghamton University.
The American Society of Retina Specialists (ASRS) today announced the launch of a new audio and video podcast series providing consumers with critical information about the signs, symptoms and risk factors of retina disease and the importance of seeing a retina specialist for specialized care.
Innovative device ensures doctors obtain adequate fluid samples from the eye, helping with diagnosis and individualized treatment plans for patients.
Human Factors and Ergonomics Society (HFES) revealed today a new brand identity which includes a new logo and website, as well as refreshed mission, vision, and tagline.
Patients taking drugs called NRTIs to treat HIV and hepatitis B had a 33% lower risk of developing diabetes.
David Williams, PhD, has been selected as the 2021 RPB David F. Weeks Award for Outstanding Vision Research. The Weeks Award, funded through the generosity of Research to Prevent Blindness, an anonymous donor, and the Association of University Professors of Ophthalmology, annually recognizes and celebrates an excellent vision researcher.
Bascom Palmer Eye Institute of the University of Miami Health System has been ranked again as the nation’s best in ophthalmology by U.S News & World Report.
This year marks the 19th time, and the 17th consecutive year, that Bascom Palmer has received the No. 1 ranking since the publication began surveying U.S. physicians for its annual “Best Hospitals” rankings 31 years ago.
Cerebral (cortical) visual impairment (CVI) is a condition that interferes with the ability of the brain to process information from the eyes, and it has become a leading cause of visual impairment in the U.S.
The Detroit Institute of Ophthalmology, the research arm of the Henry Ford Health System Department of Ophthalmology, is accepting abstracts for The Eye, The Brain & The Auto 9th World Research Congress on Health and Modern Mobility: Autonomous Vehicles, Driver’s Fitness to Function, and Naturalistic Driving Methods to be held Dec. 7-8, 2020. This will be a virtual event.
Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.
The Association for Research in Vision and Ophthalmology (ARVO) and ARVO Foundation for Eye Research announce the opening of nominations for their respective awards, including three new awards— the Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists, the Achievements in Eye and Vision Advocacy Award, and the Emerging Advocate Award—on July 1, 2020.
On July 8, the Alliance for Eye and Vision Research (AEVR) in conjunction with the Tear Film & Ocular Surface Society (TFOS) will host the Fifth Annual Dry Eye Awareness Month Congressional Briefing entitled How Lifestyle Changes During the COVID-19 Pandemic Can Affect Vision.
The National Eye Institute (NEI) has established an office to accelerate progress in regenerative medicine for eye disease and vision disorders.
New NEI-supported research provides insight into the eye conditions associated with Marfan syndrome, where weakened zonule fibers cause vision problems.
Research to Prevent Blindness announces exciting changes to its flagship grant, the RPB Career Development Award, by increasing both the amount of funding and the number of awards funded.
The discovery further challenges the accepted scientific dogma that the lens is shut out from the immune protection.
Anyone who’s ever tried to find something in a hurry knows how helpful it is to think about the lost item’s color, size and shape. But surprisingly, traits of an object that you can’t see also come into play during a search, Johns Hopkins University researchers found.
Research to Prevent Blindness and the Allergan Foundation announce new grants to increase funding for innovative research from early-career vision scientists.
An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP and can be difficult to diagnose in time to save vision.
Researchers said the wavelengths at sunrise and sunset have the biggest impact to brain centers that regulate our circadian clock and our mood and alertness.
Research to Prevent Blindness (RPB) celebrates the 60th anniversary of its incorporation. Watch the new video about its many sight-saving accomplishments over the past six decades.
Irvine, Calif., Jan. 16, 2020 — When University of California, Irvine neurobiologist Carey Y.L. Huh, Ph.D., set her sights on discovering more about amblyopia, she brought personal insight to her quest. As a child, Huh was diagnosed with the condition, which is often called “lazy eye.” he and her colleagues have just found that amblyopia originates in an earlier stage of the visual pathway than was previously thought. Their research, which raises the possibility of new treatment approaches, appears in the Journal of Neuroscience.
Georgetown neuroscientists say they have identified how people can have a “crash in visual processing” — a bottleneck of feedforward and feedback signals that can cause us not to be consciously aware of stimuli that our brain recognized.